|
Pembrolizumab injection Clinical Trials
8 actively recruiting trials across 6 locations
Also known as: Bevacizumab, CISPLATIN, KEYTRUDA®, nivolumab, ipilimumab, atlizumab, pemetrexed
Pipeline
Phase 1: 1Phase 2: 3Phase 3: 2Phase 1/2: 1
Top Sponsors
- Summit Therapeutics2
- University of Alabama at Birmingham1
- UNICANCER1
- Persephone Biosciences1
- Hunan Province Tumor Hospital1
Indications
- Cancer8
- Lung Cancer4
- Melanoma2
- Breast Cancer2
- Non Small Cell Lung Cancer2
Other2 trials
Birmingham, Alabama1 trial
Molecular Residual Disease (MRD) Guided Adjuvant ThErapy in Renal Cell Carcinoma (RCC)
University of Alabama at Birmingham
Phase 2
Chandler, Arizona1 trial
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
Clinical Study Site
Phase 3
Phoenix, Arizona1 trial
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients
Banner University Medical Center
Phase 3
Fountain Valley, California1 trial
Development and Analysis of a Stool Bank for Cancer Patients
Compassionate Care Research Group, Inc.
Irvine, California1 trial
Safety, Tolerability, and Preliminary Efficacy of CJRB-101 With Pembrolizumab in Subjects With Selected Types of Advanced or Metastatic Cancer
University of California, Irvine
Phase 1/2
Dallas, Texas1 trial
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.